RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 70 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $100,000 | -42.9% | 18,095 | 0.0% | 0.00% | – |
| Q4 2021 | $175,000 | -45.0% | 18,095 | +1.6% | 0.00% | -100.0% |
| Q3 2021 | $318,000 | -26.9% | 17,808 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $435,000 | +5.1% | 17,808 | +14.0% | 0.00% | 0.0% |
| Q1 2021 | $414,000 | +256.9% | 15,624 | +2.1% | 0.00% | – |
| Q4 2020 | $116,000 | +75.8% | 15,309 | +16.3% | 0.00% | – |
| Q3 2020 | $66,000 | -16.5% | 13,165 | 0.0% | 0.00% | – |
| Q2 2020 | $79,000 | +2.6% | 13,165 | -23.5% | 0.00% | – |
| Q1 2020 | $77,000 | -52.8% | 17,210 | 0.0% | 0.00% | – |
| Q4 2019 | $163,000 | +44.2% | 17,210 | +19.4% | 0.00% | – |
| Q3 2019 | $113,000 | -50.2% | 14,409 | 0.0% | 0.00% | – |
| Q2 2019 | $227,000 | -7.0% | 14,409 | +6.8% | 0.00% | -100.0% |
| Q1 2019 | $244,000 | – | 13,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $41,187,000 | 42.64% |
| Flagship Pioneering Inc. | 38,296,526 | $602,404,000 | 26.08% |
| HARBOURVEST PARTNERS LLC | 1,973,756 | $31,048,000 | 5.81% |
| Artal Group S.A. | 2,833,791 | $44,576,000 | 1.80% |
| EcoR1 Capital, LLC | 463,152 | $7,285,000 | 0.74% |
| Cormorant Asset Management, LP | 600,000 | $9,438,000 | 0.54% |
| Nikko Asset Management Americas, Inc. | 1,254,158 | $19,728,000 | 0.39% |
| Leap Investments LP | 14,100 | $222,000 | 0.30% |
| ARK Investment Management | 698,402 | $10,986,000 | 0.28% |
| Baillie Gifford | 4,234,682 | $66,612,000 | 0.07% |